Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: Relationship with serotonin and dopamine in the striatum

Brain Research

Volumn 1586, Issue , 2014, Pages 73-82

  Haleem, Darakhshan Jabeen ^a   Ikram, Huma ^a   Haleem, Muhammad Abdul ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

Author keywords

5 HT 1A receptors; Apomorphine; Buspirone; Conditioned place preference (CPP); Reward; sensitization

Indexed keywords

APOMORPHINE; BUSPIRONE; DOPAMINE; SEROTONIN; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOMORPHINE TEST; ARTICLE; COMPULSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG MEGADOSE; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PLACE PREFERENCE; RAT; REPEATED DRUG DOSE; REWARD; SENSITIZATION; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSTRUMENTAL CONDITIONING; METABOLISM; MOTOR ACTIVITY; WISTAR RAT;

RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BUSPIRONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONDITIONING, OPERANT; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN RECEPTOR AGONISTS;

EID: 84907612118     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.06.022     Document Type: Article

References (60)

1. Y. Ago, S. Nakamura, M. Uda, Y. Kajii, M. Abe, A. Baba, and T. Matsuda Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice Neuropharmacology 51 2006 914 922
2. M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Neurobiological mechanisms of the reinstatement of drug-conditioned place preference Brain Res. Rev. 59 2009 253 277
3. A. Antonini, C. Siri, G. Santangelo, R. Cilia, M. Poletti, M. Canesi, A. Caporali, F. Mancini, G. Pezzoli, R. Ceravolo, U. Bonuccelli, and P. Barone Impulsivity and compulsivity in drug-naïve patients with Parkinsons disease Mov. Disord. 26 2011 464 468
4. R. Carron, V. Fraix, C. Maineri, E. Seigneuret, B. Piallat, P. Krack, P. Pollak, A.L. Benabid, and S. Chabardès High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review J. Neural Transm. 118 2011 915 924
5. M.D. Doherty, and V.M. Pickel Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain J. Comp. Neurol. 433 2001 390 400
6. M. Filip, N. Alenina, M. Bader, and E. Przegaliński Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction Addict. Biol. 15 2010 227 249
7. P.J. Fletcher, A.D. Lê, and G.A. Higgins Serotonin receptors as potential targets for modulation of nicotine use and dependence Prog. Brain Res. 172 2008 361 383
8. D. Gilbert, and S.J. Cooper Beta-phenylethylamine, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats Eur. J. Pharmacol. 95 1983 311 314
9. A. Gobert, J.M. Rivet, L. Cistarelli, C. Melon, and M.J. Millan Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions Neuroscience 93 1999 1251 1262
10. J.M. Gorman Treating generalized anxiety disorder J. Clin. Psychiatry 64 Suppl. 2 2003 S24 S29
11. D.L. Graham, R. Hoppenot, A. Hendryx, and D.W. Self Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats Psychopharmacology (Berl) 191 2007 719 730
12. D.J. Haleem, H. Ikram, S. Haider, T. Parveen, and M.A. Haleem Enhancement and inhibition of apomorphine-induced sensitization in rats exposed to immobilization stress: relationship with adaptation to stress Pharmacol. Biochem. Behav. 112 2013 22 28
13. D.J. Haleem, and N.H. Khan Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 645 651
14. D.J. Haleem, H. Naz, T. Parveen, S. Haider, S.P. Ahmed, N.H. Khan, and M.A. Haleem Serotonin and serotonin1-A receptors in the failure of ethanol-treated rats to adapt to a repeated stress schedule J. Stud. Alcohol 63 2002 389 396
15. D.J. Haleem, N. Samad, and M.A. Haleem Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study Behav. Pharmacol. 18 2007 147 153
16. D.J. Haleem, N. Samad, and M.A. Haleem Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats Pharmacol. Biochem. Behav. 87 2007 115 121
17. D.J. Haleem, E. Shireen, and M.A. Haleem Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 1323 1329
18. D.J. Haleem Exaggerated feedback control decreases brain serotonin concentration and elicits hyperactivity in a rat model of diet-restriction-induced anorexia nervosa Appetite 52 2009 44 50
19. D.J. Haleem Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor Prog. Neuropsychopharmacol. Biol. Psychiatry 46 2013 170 180
20. D.J. Haleem, and M. Farhan Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine Behav. Pharmacol. 2014 in press ([Epub ahead of print])
21. D.J. Haleem, G.A. Kennett, and G. Curzon Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT J. Neural. Transm. Gen. Sect. 79 1990 93 101
22. E. Himeno, Y. Ohyagi, L. Ma, N. Nakamura, K. Miyoshi, N. Sakae, K. Motomura, N. Soejima, R. Yamasaki, T. Hashimoto, T. Tabira, F.M. LaFerla, and J. Kira Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation Ann. Neurol. 69 2011 248 256
23. D.C. Hoffman, P.R. Dickson, and R.J. Beninger The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences Prog. Neuropsychopharmacol. Biol. Psychiatry 12 1988 315 322
24. J.R. Homberg, S.F. De Boer, H.S. Raasø, J.D. Olivier, M. Verheul, E. Ronken, A.R. Cools, B.A. Ellenbroek, A.N. Schoffelmeer, L.J. Vanderschuren, T.J. De Vries, and E. Cuppen Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats Psychopharmacology (Berl) 200 2008 367 380
25. D. Hoyer, J.P. Hannon, and G.R. Martin Molecular, pharmacological and functional diversity of 5-HT receptors Pharmacol. Biochem. Behav. 71 2002 533 554
26. H. Ikram, S. Ahmad, and D.J. Haleem Effects of apomorphine on locomotive activity and monoamine metabolism: a dose related study Pak. J. Pharm. Sci. 24 2011 315 321
27. H. Ikram, A.M. Choudhry, and D.J. Haleem Regional neurochemical profile following development of apomorphine-induced reinforcement Pak. J. Pharm. Sci. 25 2012 513 519
28. H. Ikram, and D.J. Haleem Attenuation of apomorphine-induced sensitization by buspirone Pharmacol. Biochem. Behav. 99 2011 444 450
29. V. Katsidoni, I. Anagnostou, and G. Panagis Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus Addict. Biol. 18 2013 286 296
30. T.V. Khroyan, D.A. Baker, and J.L. Neisewander Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning Psychopharmacology (Berl) 122 1995 351 357
31. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238 (Erratum in: Neuropsychopharmacology 35(4):1051)
32. C. Lanteri, S.J. Hernández Vallejo, L. Salomon, E.L. Doucet, G. Godeheu, Y. Torrens, V. Houades, and J.P. Tassin Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization J. Neurosci. 29 2009 987 997
33. C. Loane, and M. Politis Buspirone: what is it all about? Brain Res. 1461 2012 111 118
34. L. Ma, Y. Ohyagi, N. Nakamura, K.M. Iinuma, K. Miyoshi, E. Himeno, N. Soejima, Y.T. Yanagihara, N. Sakae, R. Yamasaki, and J. Kira Activation of glutathione peroxidase and inhibition of p53-related apoptosis by apomorphine J. Alzheimers Dis. 27 2011 225 237
35. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice Behav. Brain Res. 121 2001 189 197
36. S.N. Mitchell, and P.J. Thomas Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain Pharmacology 37 1988 105 113
37. C.P. Müller, R.J. Carey, J.P. Huston, and M.A. De Souza Silva Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors Prog. Neurobiol. 81 2007 133 178
38. B.A. Nic Dhonnchadha, and K.A. Cunningham Serotonergic mechanisms in addiction-related memories Behav. Brain Res. 195 2008 39 53
39. M. Papp Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats Pharmacol. Biochem. Behav. 30 1988 889 893
40. A. Pazos, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors Brain Res. 346 1985 205 230
41. S.J. Peroutka Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors Biol. Psychiatry 20 1985 971 979
42. M. Pompeiano, J.M. Palacios, and G. Mengod Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding J. Neurosci. 12 1992 440 453
43. G. Pontone, J.R. Williams, S.S. Bassett, and L. Marsh Clinical features associated with impulse control disorders in Parkinson disease Neurology 67 2006 1258 1261
44. M. Riad, S. Garcia, K.C. Watkins, N. Jodoin, E. Doucet, and X. Langlois Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain J. Comp. Neurol. 417 2000 181 194
45. S. Ribarič The pharmacological properties and therapeutic use of apomorphine Molecules 17 2012 5289 5309
46. K. Rickels Buspirone in clinical practice J. Clin. Psychiatry 51 Suppl. 1990 51 54
47. H. Sershen, A. Hashim, and A. Lajtha Differences between nicotine and cocaine-induced conditioned place preferences Brain Res. Bull. 81 2010 120 124
48. E. Shireen, and D.J. Haleem Motor effects of buspirone: relationship with dopamine and serotonin in the striatum J. Coll. Physicians Surg. Pak. 15 2005 753 756
49. H. Steiner, V. Van Waes, and M. Marinelli Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers? Biol. Psychiatry 67 6 2010 592 594
50. W. Struhal, M. Guger, S. Hödl, S.C. Ung, M. Bach, and G. Ransmayr Attempted suicide under high dose dopaminergic therapy including apomorphine Wien Klin Wochenschr 124 2012 461 463
51. T.M. Tzschentke Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12 2007 227 462
52. T.M. Tzschentke Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues Prog. Neurobiol. 56 1998 613 672
53. M. van den Buuse, T. Becker, P. Kwek, S. Martin, E. Ruimschotel, and V. Risbrough Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice Int. J. Neuropsychopharmacol. 14 2011 856 861
54. V. Voon, K. Hassan, M. Zurowski, M. de Souza, T. Thomsen, S. Fox, A.E. Lang, and J. Miyasaki Prevalence of repetitive and reward-seeking behaviors in Parkinson disease Neurology 67 2006 1254 1257
55. D. Weintraub, J. Koester, M.N. Potenza, A.D. Siderowf, M. Stacy, V. Voon, J. Whetteckey, G.R. Wunderlich, and A.E. Lang Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Arch. Neurol. 67 2010 589 595
56. R.A. Wise Roles for nigrostriatal - not just mesocorticolimbic - dopamine in reward and addiction Trends Neurosci. 32 2009 517 524
57. W. Xu, Y. Wang, Z. Ma, Y.T. Chiu, P. Huang, K. Rasakham, E. Unterwald, D.Y. Lee, and L.Y. Liu-Chen l-Isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors Drug Alcohol. Depend. 133 2013 693 703
58. J.R. Yates, J.S. Beckmann, A.C. Meyer, and M.T. Bardo Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition Drug. Alcohol. Depend. 129 2013 240 246
59. Y. Zengin-Toktas, N. Authier, H. Denizot, C. Chassain, A. Hafidi, P.M. Llorca, and F. Durif Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat Neuropharmacology 70 2013 74 82
60. D. Zheng, S. Liu, S. Cabeza de Vaca, and K.D. Carr Effects of time of feeding on psychostimulant reward, conditioned place preference, metabolic hormone levels, and nucleus accumbens biochemical measures in food-restricted rats Psychopharmacology (Berl) 227 2013 307 320